EICHORCondition: Venous Leg Ulcer (VLU) · Compression Bandages · Sponsor: Molnlycke Health Care AB
Interested? Contact the study team ↓
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
Venous leg ulcers (VLUs) account for approximately 70% of all lower limb ulcers and affect an estimated 0.032% to 1% of the population in Western countries, corresponding to approximately 265,000 to 650,000 individuals in France. Effective management of VLUs is essential to reduce patient burden and associated healthcare costs. Compression therapy is the cornerstone of VLU treatment , as it improves venous return, reduces oedema, and promotes wound healing. Multilayer compression bandage systems, including two-layer systems, are considered the gold standard, and in France, they are recommended as first-line treatment for VLUs. The goal of this clinical trial is to evaluate whether the Mepi™ Press 2 compression system is non-inferior to UrgoK2® in the treatment of venous leg ulcers in adult patients. The main question it aims to answer is: -Is Mepi™ Press 2 non-inferior to UrgoK2® in terms of the proportion of completely healed VLUs within 12 weeks? Researchers will compare Mepi™ Press 2 with UrgoK2® to determine whether similar clinical efficacy, performance, and safety can be achieved. Participants are adult patients with venous leg ulcers of less than 24 months duration requiring treatment with a two-layer compression bandage system. The study is multicenter, involving approximately 25 sites in France, and plans to enroll 386 participants. Participants will: * Receive compression therapy with either Mepi™ Press 2 or UrgoK2® in accordance with standard of care * Recei…
This description comes directly from the study's public registry record.
Clinical Project Manager · +46 (0)31- 722 31 96 · kristina.welinder@molnlycke.com
There is no obligation to join — the study team can answer your questions about taking part.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * Patients ≥ 18 years. * Stage C6 venous leg ulcer diagnosed less than 24 months ago. * 2cm² ≤ VLU surface area ≤ 40cm². * ABPI equal or higher than 0.8 and equal or lower than 1.3. * Able to read, understand and speak French for their medical care. * Agreeing to follow the procedures described in the CIP. * Benefiting from a social insurance coverage. Exclusion Criteria: * Any contraindication to investigational or comparator medical devices mentioned in their respective IFUs. * Planned endovenous treatment or surgical venous stripping / exeresis within 8 weeks before planned inclusion date, or before end of participation to the study. * Treatment with chemotherapy or antineoplastic agent within the last 6 months. * Active wound infection or wound infection treatment within the past 4 weeks before inclusion or current use of silver dressings. * Pregnant or breastfeeding women. * Persons deprived from their liberty. * Persons protected under guardianship or curatorship. * Any person who, as per investigator's decision, is not suitable to participate in the investigation for any other reason.-
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Clinique du Parc-Montpellier | Castelnau-le-Lez, France | — |
| CHU Michallon Grenoble | Grenoble, France | — |
| Clinique du Parc Lyon | Lyon, France | — |
| Hopital Edouard Herriot_HCL | Lyon, France | — |
| CHU Nantes | Nantes, France | — |
| Poitiers Polyclinique | Poitiers, France | — |
| CHU Toulouse/Hopital Rangueil | Toulouse, France | — |
| Clinique Pasteur-Toulouse | Toulouse, France | — |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07600489